Advertisement
Screener

Dyne Therapeutics, Inc. (DYN) Outstanding Bonds: Outstanding

Dyne Therapeutics, Inc. Outstanding Bonds

Note series still outstanding, nearest maturity first. Terms are from each offering's final pricing term sheet on SEC EDGAR; a reopening of the same CUSIP adds to its principal. Interest per payment = principal × coupon ÷ payments per year. Outstanding = principal issued minus each filed exchange, tender, redemption or conversion; it is (m) where the retired amount was not filed. Interest per payment uses the outstanding principal.

NotesPrincipal issuedOutstandingCouponTrade dateIssue / settlement dateMaturity dateInterest payment datesInterest per paymentAnnual coupon interestOptional redemptionRetiredPriced

Similar stocks

Stock NameCountryMarket CapPE Ratio
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
PRECIGEN, INC. (PGEN)United States$2.757B-12.94
NewAmsterdam Pharma Co N.V. (NAMS)$2.719B-15.37
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
Disc Medicine, Inc. (IRON)United States$2.553B-11.40